Complementary and alternative medicine use in lung cancer patients in eight European countries
- PMID: 16401528
- DOI: 10.1016/j.ctcp.2005.09.007
Complementary and alternative medicine use in lung cancer patients in eight European countries
Abstract
This paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients.
Similar articles
-
Complementary and alternative medicine use in patients with haematological malignancies in Europe.Complement Ther Clin Pract. 2005 May;11(2):105-10. doi: 10.1016/j.ctcp.2004.12.005. Complement Ther Clin Pract. 2005. PMID: 15955292
-
Complementary and alternative medicine use in colorectal cancer patients in seven European countries.Complement Ther Med. 2005 Dec;13(4):251-7. doi: 10.1016/j.ctim.2005.07.002. Epub 2005 Sep 19. Complement Ther Med. 2005. PMID: 16338195
-
Use of complementary and alternative medicine among cancer patients in Israel.Eur J Oncol Nurs. 2005 Jun;9(2):124-30. doi: 10.1016/j.ejon.2005.03.011. Eur J Oncol Nurs. 2005. PMID: 15944105
-
Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.Eur J Cancer Care (Engl). 2007 Mar;16(2):144-9. doi: 10.1111/j.1365-2354.2006.00722.x. Eur J Cancer Care (Engl). 2007. PMID: 17371423 Review.
-
Complementary and alternative therapies in occupational health. Part II--Specific therapies.AAOHN J. 2002 Oct;50(10):468-77; quiz 478-9. AAOHN J. 2002. PMID: 12400231 Review.
Cited by
-
The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study.Curr Oncol. 2013 Jun;20(3):152-7. doi: 10.3747/co.20.1312. Curr Oncol. 2013. PMID: 23737683 Free PMC article.
-
Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.Clin Med (Lond). 2013 Apr;13(2):126-31. doi: 10.7861/clinmedicine.13-2-126. Clin Med (Lond). 2013. PMID: 23681857 Free PMC article.
-
Treatment of Lung Cancer with Orally Administered Chinese Herbal Medicine: An Evidence Map between 1970-2020.Chin J Integr Med. 2022 Oct;28(10):930-938. doi: 10.1007/s11655-022-3465-3. Epub 2022 Mar 3. Chin J Integr Med. 2022. PMID: 35243583 Review.
-
Integrative cancer treatment may have a survival benefit in patients with lung cancer: A retrospective cohort study from an integrative cancer center in Korea.Medicine (Baltimore). 2019 Jun;98(26):e16048. doi: 10.1097/MD.0000000000016048. Medicine (Baltimore). 2019. PMID: 31261510 Free PMC article.
-
Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon.Evid Based Complement Alternat Med. 2017;2017:8434697. doi: 10.1155/2017/8434697. Epub 2017 Aug 24. Evid Based Complement Alternat Med. 2017. PMID: 28912824 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials